Skip To Main Content
Jamile Frayfer on Muck Rack

Jamile Frayfer

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jamile

Contact Jamile, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort

|
By Lin Zhao, Céline Berthon, Laurène Fenwarth, Stephane de Botton, Thomas Cluzeau, Laure Farnault, Sylvain Chantepie, Pierre Arnautou, Thorsten Braun, Mathieu Leclerc, Delphine Lebon Verified, Juliette Lambert, Christophe Willekens, Emmanuel Raffoux, Ambroise Marçais, Pascal Turlure, Benjamin Carpentier, Madalina Uzunov, Reda Garidi, Alexandra Prado Coelho Verified, Karine Celli-Lebras, Raphael Itzykson, Claude Preudhomme, Nicolas Duployez, Hervé Dombret, Lionel Ades, Ahmad Aljijakli, Isabelle Plantier, Ollivier Legrand, Claire Bories, Emilie Lemasle, Kevin-James Wattebled, Celia Salanoubat, Jamile Frayfer, Iona Vaida, Renaud Buffet
| Nature Verified
Acute myeloid leukemia (AML) predominantly affects older adults, with two-thirds of cases diagnosed after the age of 60 [1]. In this population, therapeutic options have significantly expanded: intensive chemotherapy (ICT) remains the standard for fit patients, whereas venetoclax (Ven)–based low-intensity therapies (LIT) are increasingly used.
Open in Who Shared Issue with article?
See all 1 articles